Adamas Announces New Employment Inducement Grant

Rhea-AI Summary

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) announced the granting of 22,500 restricted stock units to three new employees. These units will vest over three years and were issued under the 2016 Inducement Plan, approved by the board in March 2016. This initiative aims to attract talent to support the company's vision of delivering innovative treatments for neurological diseases.

Adamas is committed to developing therapies that alleviate the impact of neurological disorders on patients and the broader society.

Positive

• Issuance of 22,500 restricted stock units indicates commitment to attract talent.
• The vesting period of three years aligns with long-term company growth objectives.

Negative

• None.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted three new employees restricted stock units to acquire 22,500 shares of the company’s common stock. The restricted stock units vest over three years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company's board of directors in March 2016 under Rule 5653(c)(4) of the Nasdaq Global Market for equity grants to induce new employees to enter into employment with the company.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210611005447/en/

FAQ

What are the details of Adamas Pharmaceuticals' restricted stock units granted?

Adamas Pharmaceuticals granted 22,500 restricted stock units to three new employees that will vest over three years.

What was the purpose of the restricted stock units granted by Adamas Pharmaceuticals?

The restricted stock units aim to induce new employees to join the company as part of their talent acquisition strategy.

Under which plan were the restricted stock units granted by Adamas Pharmaceuticals?

The restricted stock units were granted under the Adamas Pharmaceuticals 2016 Inducement Plan.

When was the 2016 Inducement Plan approved for Adamas Pharmaceuticals?

The 2016 Inducement Plan was approved by the board of directors in March 2016.

What is the vision of Adamas Pharmaceuticals?

Adamas Pharmaceuticals aims to deliver innovative medicines that alleviate the burden of neurological diseases on patients and caregivers.